Novel plga-modified polyethylenimine self-assembly nanotechnology for nucleic acid and drug delivery
AssigneeBaylor College of Medicine
InventorsJian-Ming Lu, Qizhi Yao, Changyi Chen
Life of this patent
Estimating the term…
Loading patent…
AssigneeBaylor College of Medicine
InventorsJian-Ming Lu, Qizhi Yao, Changyi Chen
Estimating the term…
Embodiments of the invention concern copolymers and nanoparticles for use as delivery agents for one or more agents for therapy for a medical condition of humans and animals. Some of embodiments of the invention provide new reagents for biomedical research in cell culture, animal models and plants, for example. The copolymers comprise PLGA and PEI and, in some embodiments, also comprise 1-(3-aminopropyl)-4-methylpiperazine (APMP), Fc binding peptide and/or antibody. In certain embodiments, APMP-PLGA-PEI, Fc binding peptide/antibody-PLGA-PEI or Fc binding peptide/antibody-APMP-PLGA-PEI nanoparticles comprising one or more therapeutic agents are delivered to an individual in need thereof or used for biomedical research in cell cultures, animal models and plants.
A composition comprising:
A composition comprising:
A method of making a composition comprising at least one therapeutic and/or diagnostic agent and a copolymer consisting of lactide-co-glycolide and PEI, the method comprising the steps of:
A copolymer composition comprising
Dependencies are inferred from the claim text.